Have LLMs improved patient outcomes?
Summary
Cardiologist and author Eric Topol's latest review concludes that there is "very little evidence for LLMs benefiting patients or doctors for health outcomes," beyond administrative tasks. This finding aligns with a recent editorial in Nature Medicine, which also indicates a lack of direct evidence for large language models improving health outcomes. The analysis supports earlier warnings about the unsupervised use of LLMs for medical advice, suggesting that while AI holds future promise for medicine, current domain-general chatbots may not be suitable for direct clinical applications or patient-facing medical guidance. The consensus points to a gap between the potential of AI in healthcare and the current demonstrable impact of LLMs on patient and physician health outcomes.
Key takeaway
For AI Product Managers developing healthcare solutions, you should prioritize applications that address administrative burdens rather than direct patient health outcomes. The current evidence suggests that general-purpose LLMs lack the validated efficacy for clinical use, indicating a need for more specialized, evidence-based AI tools before widespread adoption in patient care. Focus on demonstrating clear, measurable benefits in specific, non-clinical workflows.
Key insights
Current LLMs show minimal evidence of directly improving patient or doctor health outcomes.
Principles
- AI's medical benefits are largely administrative.
- Domain-general chatbots are not yet clinically ready.
In practice
- Review LLM applications for administrative efficiency.
- Exercise caution with LLMs for direct patient care.
Topics
- LLMs in Medicine
- Patient Outcomes
- Medical AI Implementation
- Chatbot Medical Advice
- Eric Topol
Best for: AI Product Manager, Research Scientist, AI Scientist, AI Ethicist
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Marcus on AI.